[Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing]

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Context:

• Osteosarcoma is a primary bone malignancy with diverse genetic alterations.
• Understanding gene mutation profiles is crucial for developing targeted therapies.
• Previous studies have identified various mutations, but comprehensive analysis is ongoing.

Purpose:

• To investigate the spectrum and characteristics of gene mutations in osteosarcoma.
• To determine the frequency and types of detectable mutations.
• To identify potential therapeutic targets for individualized osteosarcoma treatment.

Summary:

• Next-generation sequencing of 64 osteosarcoma samples revealed an 84.4% mutation detection rate.
• TP53 was the most frequently mutated gene (32.8%), followed by VEGFA, CCND3, and ATRX.
• Common alterations included copy number variations, single nucleotide variants, and insertions/deletions, with TP53 mutations playing a key role in pathogenesis.

Impact:

• Identifies key mutated genes (TP53, VEGFA, CCND3, ATRX) in osteosarcoma.
• Highlights the potential of next-generation sequencing for guiding individualized treatment in refractory, recurrent, or metastatic cases.
• Provides a foundation for further research into targeted therapies for osteosarcoma.